Prot #LJ501-EAP01: Expanded Access for LJPC-501 (Angiotensin II)

Project: Research project

Project Details

StatusActive
Effective start/end date10/26/1710/26/20

Funding

  • La Jolla Pharmaceutical Company (Prot #LJ501-EAP01)